Tunatura Shares of Aquestive Therapeutics (NASDAQ:AQST) have fallen by over 90% since their $67.5M IPO was priced at $15 in 2018. So far in 2022, the company has lost two-thirds of its value after a […]
Jitalia17 It has been almost a year since I reviewed the iShares Core Growth Allocation ETF (NYSEARCA:AOR), a comparatively low-cost multi-asset fund providing exposure to the classic 60/40 portfolio favored by investors for decades. AOR’s […]
gorodenkoff Thesis Aurora Innovation (NASDAQ:AUR) stock surged as much as 25% on Friday, 2nd September, after a company-internal memo hinted on Apple (AAPL) and Microsoft (MSFT) as potential acquirers of the company. Although the named […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.